Director, Apixaban Global Marketing - ACS Lead
Bristol-Myers Squibb-Princeton, NJ, 08540
The individual in this role will have primary responsibility for leading the commercialization of the Acute Coronary Syndrome (ACS) indication for Apixaban, a novel Factor Xa oral anticoagulant. Specifically, the person in this role will refine the market map and prioritize business opportunities to drive the commercialization planning for Apixaban's ACS indication. The individual will also work closely with the Clinical and Medical Affairs teams to define the market development strategy for ACS, and to develop and begin executing a plan to address these needs. The person in this role will ...